Objectives:
- Understand the current biomarker landscape in gastric/gastroesophageal and colorectal cancer
- Understand the implications of biomarker studies on the prognosis and treatment of gastric/gastroesophageal and colorectal cancer
- Understand what biomarkers will be available in the future and their implications on gastric/gastroesophageal and colorectal cancer
Needs:
- New advances in pathologic analysis
- New methods of diagnosis or treatment
- Development of new technology
- Advances in medical knowledge
References:
- Nakamura Y, et al. Biomarker-targeted therapies for advanced-stage gastric and gastro-oesophageal junction cancers: an emerging paradigm. Nat Rev Clin Oncol. 2021;18:473-487.
- Ivanova M, et al. HER2 in metastatic colorectal cancer: pathology, somatic alterations, and perspectives for novel therapeutic schemes. Life. 2022;12:1403.
Core Competencies: 2,3,6,7